FFVAX | FPTKX | FFVAX / FPTKX | |
Total Expense Ratio | 0.77 | 0.26 | 296% |
Annual Report Gross Expense Ratio | 0.77 | 0.26 | 296% |
Fund Existence | 22 years | 8 years | - |
Gain YTD | 2.787 | 3.619 | 77% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 430M | 4.32B | 10% |
Annual Yield % from dividends | 2.48 | 3.07 | 81% |
Returns for 1 year | 4.13 | 5.54 | 75% |
Returns for 3 years | 18.64 | 21.67 | 86% |
Returns for 5 years | 4.07 | 7.74 | 52% |
Returns for 10 years | -2.28 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FGSAX | 62.20 | N/A | N/A |
Federated Hermes MDT Mid Cap Growth A | |||
EIVPX | 15.70 | -0.07 | -0.44% |
Parametric Volatil Risk Prm-Defensv I | |||
NCAVX | 11.84 | -0.13 | -1.09% |
Nuance Concentrated Value Investor | |||
WPOIX | 11.84 | -0.14 | -1.17% |
Weitz Partners III Opportunity Investor | |||
CEUCX | 55.41 | -0.69 | -1.23% |
American Funds EUPAC 529-C |